SOD1 and amyotrophic lateral sclerosis: Selective expression of mutant SOD1 in mouse skeletal muscle using the myosin light chain (MLC) promoter (MCL/SOD1G93A) induced ALS-like muscle pathologies, including progressive muscle atrophy, reduced muscle strength, impaired contractility, and mitochondrial dysfunction (Dobrowolny et al., 2008).